There was no significant difference in the percentage of positive cell expression of 2B4, CS1 and NKp46 on CD3+ T cells in the different risk-stratified groups of ALL subjects as compared to healthy subjects either at diagnosis (1BD) or post-induction chemotherapy (2BD) treatment (Figure 2A–D,I,J). The gene discussed is CD244; the disease is acute lymphoblastic leukemia.